These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28434792)

  • 1. Cloning and expression patterns of neuromedin U and its receptors in pigs.
    Li X; Niu M; Su J; Ma Z; Jin M; Qiao W; Zhang Y; Feng Y; An N; Hou Y; Yang S; Chuan S; Lei Z
    Neuropeptides; 2017 Aug; 64():47-60. PubMed ID: 28434792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postnatal developmental of Neuromedin S and its receptor in the male Xiaomeishan pig reproductive axis.
    Ma Z; Zhao Y; Yao Y; Lei Z; Jin M; Li X; Jia C; Zhang Z; Li X; Su J
    Anim Reprod Sci; 2017 Jun; 181():115-124. PubMed ID: 28389048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two chicken neuromedin U receptors: characterization of primary structure, biological activity and tissue distribution.
    Yamamoto I; Nakao N; Kaiya H; Miyazato M; Tsushima N; Arai T; Tanaka M
    Gen Comp Endocrinol; 2011 Nov; 174(2):116-23. PubMed ID: 21878335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of neuromedin U (NMU), neuromedin S (NMS) and their receptors (NMUR1, NMUR2) in chickens.
    Wan Y; Zhang J; Fang C; Chen J; Li J; Li J; Wu C; Wang Y
    Peptides; 2018 Mar; 101():69-81. PubMed ID: 29288685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice.
    Kaisho T; Nagai H; Asakawa T; Suzuki N; Fujita H; Matsumiya K; Nishizawa N; Kanematsu-Yamaki Y; Dote K; Sakamoto JI; Asami T; Takekawa S
    Int J Obes (Lond); 2017 Dec; 41(12):1790-1797. PubMed ID: 28757640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromedin U induces an invasive phenotype in CRC cells expressing the NMUR2 receptor.
    Przygodzka P; Sochacka E; Soboska K; Pacholczyk M; Papiewska-Pająk I; Przygodzki T; Płociński P; Ballet S; De Prins A; Boncela J
    J Exp Clin Cancer Res; 2021 Sep; 40(1):283. PubMed ID: 34493299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromedin U inhibits food intake partly by inhibiting gastric emptying.
    Dalbøge LS; Pedersen SL; Secher T; Holst B; Vrang N; Jelsing J
    Peptides; 2015 Jul; 69():56-65. PubMed ID: 25895852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying a Neuromedin U Receptor 2 Splice Variant and Determining Its Roles in the Regulation of Signaling and Tumorigenesis In Vitro.
    Lin TY; Huang WL; Lee WY; Luo CW
    PLoS One; 2015; 10(8):e0136836. PubMed ID: 26317338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian regulation of neuromedin U and its local actions in the ovary, mediated through neuromedin U receptor 2.
    Lin TY; Wu FJ; Lee WY; Hsiao CL; Luo CW
    Am J Physiol Endocrinol Metab; 2013 Apr; 304(8):E800-9. PubMed ID: 23423171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2).
    Peier A; Kosinski J; Cox-York K; Qian Y; Desai K; Feng Y; Trivedi P; Hastings N; Marsh DJ
    Endocrinology; 2009 Jul; 150(7):3101-9. PubMed ID: 19324999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and pharmacological characterization of a small-molecule antagonist at neuromedin U receptor NMUR2.
    Liu JJ; Payza K; Huang J; Liu R; Chen T; Coupal M; Laird JM; Cao CQ; Butterworth J; Lapointe S; Bayrakdarian M; Trivedi S; Bostwick JR
    J Pharmacol Exp Ther; 2009 Jul; 330(1):268-75. PubMed ID: 19369576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromedins NMU and NMS: An Updated Overview of Their Functions.
    Malendowicz LK; Rucinski M
    Front Endocrinol (Lausanne); 2021; 12():713961. PubMed ID: 34276571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of neuromedins S and U and their receptors in the hypothalamus and endocrine glands of the rat.
    Rucinski M; Ziolkowska A; Neri G; Trejter M; Zemleduch T; Tyczewska M; Nussdorfer GG; Malendowicz LK
    Int J Mol Med; 2007 Aug; 20(2):255-9. PubMed ID: 17611645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromedin U directly stimulates growth of cultured rat calvarial osteoblast-like cells acting via the NMU receptor 2 isoform.
    Rucinski M; Ziolkowska A; Tyczewska M; Szyszka M; Malendowicz LK
    Int J Mol Med; 2008 Sep; 22(3):363-8. PubMed ID: 18698496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insights into the peptide selectivity and activation of human neuromedin U receptors.
    You C; Zhang Y; Xu P; Huang S; Yin W; Eric Xu H; Jiang Y
    Nat Commun; 2022 Apr; 13(1):2045. PubMed ID: 35440625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromedin U receptor 1 expression in the rat endocrine pancreas and evidence suggesting neuromedin U suppressive effect on insulin secretion from isolated rat pancreatic islets.
    Kaczmarek P; Malendowicz LK; Pruszynska-Oszmalek E; Wojciechowicz T; Szczepankiewicz D; Szkudelski T; Nowak KW
    Int J Mol Med; 2006 Nov; 18(5):951-5. PubMed ID: 17016626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromedin U: physiology, pharmacology and therapeutic potential.
    Budhiraja S; Chugh A
    Fundam Clin Pharmacol; 2009 Apr; 23(2):149-57. PubMed ID: 19645813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel neuromedin U receptor subtype expressed in the central nervous system.
    Shan L; Qiao X; Crona JH; Behan J; Wang S; Laz T; Bayne M; Gustafson EL; Monsma FJ; Hedrick JA
    J Biol Chem; 2000 Dec; 275(50):39482-6. PubMed ID: 11010960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of neuromedin U type 1 receptor inhibits L-type Ca2+ channel currents via phosphatidylinositol 3-kinase-dependent protein kinase C epsilon pathway in mouse hippocampal neurons.
    Zhang Y; Jiang D; Zhang J; Wang F; Jiang X; Tao J
    Cell Signal; 2010 Nov; 22(11):1660-8. PubMed ID: 20599609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromedin U uses Gαi2 and Gαo to suppress glucose-stimulated Ca2+ signaling and insulin secretion in pancreatic β cells.
    Zhang W; Sakoda H; Nakazato Y; Islam MN; Pattou F; Kerr-Conte J; Nakazato M
    PLoS One; 2021; 16(4):e0250232. PubMed ID: 33857254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.